Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carisbamate vs Topiramate and Levetiracetam in Partial Onset Seizures
NCT00563459Phase 3Terminated
- Sponsor
- SK Life Science, Inc.
- Start
- Nov 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of carisbamate in focal onset seizure (3 arms), sponsored by SK Life Science, Inc. Primary endpoint: Time to Discontinuation at 6 months. Started Nov 2007; status: terminated.
02
Drugs
carisbamate
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00563459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00563459.